Education
About Us
Working with TipRanks
Follow Us
James L. Tyree Insider Profile
11 Followers
James L. Tyree, Director at Innoviva, holds 68.07K shares in Genelux Corp. (Ticker: GNLX), holds 188.25K shares in Assertio Therapeutics (Ticker: ASRT), holds 0.00 shares in ChemoCentryx (Ticker: ~CCXI).
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+12.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that James L. Tyree holds in companies
Most Profitable Insider Trade
The most profitable trade made by James L. Tyree
James L. Tyree's Trading History
Innoviva
Apr 24, 2017
Director
Uninformative Buy
―
$754.23K
Assertio Therapeutics
Mar 15, 2024
Director
Informative Sell
11.38K
$2.27M
Genelux Corp.
Aug 29, 2025
Director
Uninformative Buy
―
$182.44K
ChemoCentryx
Oct 24, 2022
―
Uninformative Sell
―
$0.00
Abbott Laboratories
Mar 03, 2009
EVP
Uninformative Sell
843.06K
$15.08M
List of latest transactions for each holding click on a transaction to see James L. Tyree's performance on stock
You May Also Like
James L. Tyree insider profile FAQ
What is the percentage of profitable transactions made by James L. Tyree?
The percentage of profitable transactions made by James L. Tyree is 67%.
What is the average return per transaction made by James L. Tyree?
The average return per transaction made by James L. Tyree is 12.90%.
What stocks does James L. Tyree hold?
James L. Tyree holds: INVA, ASRT, GNLX, ~CCXI, ABT stocks.
What was James L. Tyree’s latest transaction?
James L. Tyree latest transaction was an Uninformative Buy of ―.
What was James L. Tyree's most profitable transaction?
James L. Tyree’s most profitable transaction was an Informative Sell of GNLX stock on December 14, 2023. The return on the trade was 84.20%.
What is James L. Tyree's role in Innoviva?
James L. Tyree's role in Innoviva is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.